Raphael Pharmaceutical Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Raphael Pharmaceutical Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-03-31 was $149.00K, a 6.87% decline year-over-year.
- Raphael Pharmaceutical Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-09-30 was $63.00K.
- Raphael Pharmaceutical Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-06-30 was $352.00K.
- Raphael Pharmaceutical Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-03-31 was $160.00K.
- Raphael Pharmaceutical Inc. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $893.00K, a 30.78% decline from fiscal 2021.
- Raphael Pharmaceutical Inc. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $1.29M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2023-03-31 | $149.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $893.00K 10-K/A · filed 2023-05-25 | |
| 2022-09-30 | $63.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $352.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $160.00K 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $1.29M 10-K/A · filed 2023-05-25 |